How race and secondary conditions influence diabetes clinical trial interest
The impact of secondary conditions on clinical trial interest.
Across multiple demographics, accommodations boost patient interest in clinical trial participation and barriers lower interest
Strategies to boost diversity in clinical trials.
Spanish-speaking patients show strong interest in clinical trial participation in the US.
For a clinical trial to be successful, patients need to be the top priority. However, language barriers faced during the clinical trial process can often result in lower participation rates of non-English speakers, an unsatisfactory patient experience and, ultimately, imprecise data. In the US, the leading country in clinical trial participation each year, language barriers […]
Concerns around clinical trial participation continue to differ by race.
Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages […]
How to Boost Diversity in Clinical Trial Patient Recruitment
Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts.
RWE Won’t Replace Clinical Trials – But It Can Improve Them
Although real world evidence (RWE) is gaining steam in the healthcare industry, it doesn’t pose a threat to traditional clinical trials. Here’s what sponsors and CRO’s need to know:
Precision Medicine Highlights the Importance of Diversity in Clinical Trials
In order to determine the safety and efficacy of new treatments, it’s crucial for clinical trials to recruit racially and ethnically diverse patients.
Study Shows Patients Are Open to Clinical Trials, But Can’t Find Them
In a recent study, 73% of people who had not participated in a clinical trial reported they would be open to doing so. Now it’s up to sponsors and CROs to engage this untapped audience.
Increasing African-American Enrollment in Clinical Trials through Holistic Recruitment
African-Americans are underrepresented in many clinical trials. Here are three steps CROs and sponsors can take to improve recruitment of minority patients.
